Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility.
Kresken M, Klare I, Wichelhaus TA, Wohlfarth E, Layer-Nicolaou F, Neumann B, Werner G; Study Group ‘Antimicrobial Resistance’ of the Paul-Ehrlich-Society for Chemotherapy. Kresken M, et al. Among authors: wohlfarth e. J Glob Antimicrob Resist. 2022 Mar;28:102-107. doi: 10.1016/j.jgar.2021.12.016. Epub 2021 Dec 25. J Glob Antimicrob Resist. 2022. PMID: 34958996 Free article.
The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010-2019.
Wohlfarth E, Kresken M, Higgins PG, Stefanik D, Wille J, Hafner D, Körber-Irrgang B, Seifert H; Study Group “Antimicrobial Resistance” of the Paul-Ehrlich-Society for Infection Therapy. Wohlfarth E, et al. Int J Antimicrob Agents. 2022 Nov-Dec;60(5-6):106689. doi: 10.1016/j.ijantimicag.2022.106689. Epub 2022 Nov 12. Int J Antimicrob Agents. 2022. PMID: 36375774
Susceptibility of Multidrug-Resistant Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa from Germany to Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Imipenem-Relebactam.
Kresken M, Wohlfarth E, Wichelhaus TA, Gatermann SG, Pfennigwerth N, Eisfeld J, Seifert H; German BL/BLI Study Group. Kresken M, et al. Among authors: wohlfarth e. Microb Drug Resist. 2023 Apr;29(4):138-144. doi: 10.1089/mdr.2022.0175. Epub 2023 Jan 9. Microb Drug Resist. 2023. PMID: 36622756
In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17.
Wohlfarth E, Kresken M, Deuchert F, Gatermann SG, Pfeifer Y, Pfennigwerth N, Seifert H, Higgins PG, Werner G, Study Group 'Antimicrobial Resistance' Of The Paul Ehrlich Society For Infection Therapy. Wohlfarth E, et al. Antibiotics (Basel). 2023 May 6;12(5):864. doi: 10.3390/antibiotics12050864. Antibiotics (Basel). 2023. PMID: 37237767 Free PMC article.
15 results